References analysis of the Wikipedia article "Calpaína" in the Galician version

archive.org

Lenzlinger PM, Saatman KE, Raghupathi R, Mcintosh TK (2000). "Chapter 1: Overview of basic mechanisms underlying neuropathological consequences of head trauma". En Newcomb JK, Miller LS, Hayes RL. Head trauma: basic, preclinical, and clinical directions. New York: Wiley-Liss. ISBN 978-0-471-36015-5.

doi.org

dx.doi.org

Ohno S, Emori Y, Imajoh S, Kawasaki H, Kisaragi M, Suzuki K (1984). "Evolutionary origin of a calcium-dependent protease by fusion of genes for a thiol protease and a calcium-binding protein?". Nature 312 (5994): 566–70. PMID 6095110. doi:10.1038/312566a0.

Glass JD, Culver DG, Levey AI, Nash NR (April 2002). "Very early activation of m-calpain in peripheral nerve during Wallerian degeneration". J. Neurol. Sci. 196 (1–2): 9–20. PMID 11959150. doi:10.1016/S0022-510X(02)00013-8.

Cuerrier D, Moldoveanu T, Davies PL (December 2005). "Determination of peptide substrate specificity for mu-calpain by a peptide library-based approach: the importance of primed side interactions". J. Biol. Chem. 280 (49): 40632–41. PMID 16216885. doi:10.1074/jbc.M506870200.

Huang Y, Wang KK (August 2001). "The calpain family and human disease". Trends Mol Med 7 (8): 355–62. PMID 11516996. doi:10.1016/S1471-4914(01)02049-4.

Suzuki K, Hata S, Kawabata Y, Sorimachi H (February 2004). "Structure, activation, and biology of calpain". Diabetes. 53. Suppl 1: S12–8. PMID 14749260. doi:10.2337/diabetes.53.2007.s12.

Jaguva Vasudevan, AA; Perkovic, M; Bulliard, Y; Cichutek, K; Trono, D; Häussinger, D; Münk, C (August 2013). "Prototype foamy virus Bet impairs the dimerization and cytosolic solubility of human APOBEC3G.". Journal of Virology 87 (16): 9030–40. PMC 3754047. PMID 23760237. doi:10.1128/JVI.03385-12.

Du, Manting; Li, Xin; Li, Zheng; Shen, Qingwu; Wang, Ying; Li, Guixia; Zhang, Dequan (2018-06-30). "Phosphorylation regulated by protein kinase A and alkaline phosphatase play positive roles in μ-calpain activity". Food Chemistry (en inglés) 252: 33–39. ISSN 0308-8146. PMID 29478550. doi:10.1016/j.foodchem.2018.01.103.

Tyagi, T.; Ahmad, S.; Gupta, N.; Sahu, A.; Ahmad, Y.; Nair, V.; Chatterjee, T.; Bajaj, N.; Sengupta, S.; Ganju, L.; Singh, S. B.; Ashraf, M. Z. (Feb 2014). "Altered expression of platelet proteins and calpain activity mediate hypoxia-induced prothrombotic phenotype.". Blood 123 (8): 1250–60. PMID 24297866. doi:10.1182/blood-2013-05-501924.

Belcastro AN, Albisser TA, Littlejohn B (October 1996). "Role of calcium-activated neutral protease (calpain) with diet and exercise". Can J Appl Physiol 21 (5): 328–46. PMID 8905185. doi:10.1139/h96-029.

Richard I, Broux O, Allamand V, et al. (April 1995). "Mutations in the proteolytic enzyme calpain 3 cause limb-girdle muscular dystrophy type 2A". Cell 81 (1): 27–40. PMID 7720071. doi:10.1016/0092-8674(95)90368-2.

Ono Y, Shimada H, Sorimachi H, et al. (July 1998). "Functional defects of a muscle-specific calpain, p94, caused by mutations associated with limb-girdle muscular dystrophy type 2A". J. Biol. Chem. 273 (27): 17073–8. PMID 9642272. doi:10.1074/jbc.273.27.17073.

Yamashima T (2013). "Reconsider Alzheimer's disease by the 'calpain-cathepsin hypothesis'--a perspective review". Progress in Neurology 105: 1–23. PMID 23499711. doi:10.1016/j.pneurobio.2013.02.004.

Liu J, Liu MC, Wang KK (April 2008). "Calpain in the CNS: from synaptic function to neurotoxicity". Sci. Signal. 1 (14): re 1. PMID 18398107. doi:10.1126/stke.114re1.

Castillo MR, Babson JR (October 1998). "Ca²⁺-dependent mechanisms of cell injury in cultured cortical neurons". Neuroscience 86 (4): 1133–44. PMID 9697120. doi:10.1016/S0306-4522(98)00070-0.

Iwata A, Stys PK, Wolf JA, et al. (May 2004). "Traumatic axonal injury induces proteolytic cleavage of the voltage-gated sodium channels modulated by tetrodotoxin and protease inhibitors". J. Neurosci. 24 (19): 4605–13. PMC 6729402. PMID 15140932. doi:10.1523/JNEUROSCI.0515-03.2004.

Wang KK, Larner SF, Robinson G, Hayes RL (December 2006). "Neuroprotection targets after traumatic brain injury". Curr. Opin. Neurol. 19 (6): 514–9. PMID 17102687. doi:10.1097/WCO.0b013e3280102b10.

Wang KK, Nath R, Posner A, Raser KJ, Buroker-Kilgore M, Hajimohammadreza I, Probert AW, Marcoux FW, Ye Q, Takano E, Hatanaka M, Maki M, Caner H, Collins JL, Fergus A, Lee KS, Lunney EA, Hays SJ, Yuen P (June 1996). "An alpha-mercaptoacrylic acid derivative is a selective nonpeptide cell-permeable calpain inhibitor and is neuroprotective". Proc. Natl. Acad. Sci. U.S.A. 93 (13): 6687–92. PMC 39087. PMID 8692879. doi:10.1073/pnas.93.13.6687.

Kupina NC, Nath R, Bernath EE, Inoue J, Mitsuyoshi A, Yuen PW, Wang KK, Hall ED (November 2001). "The novel calpain inhibitor SJA6017 improves functional outcome after delayed administration in a mouse model of diffuse brain injury" (PDF). J. Neurotrauma 18 (11): 1229–40. PMID 11721741. doi:10.1089/089771501317095269. hdl:2027.42/63231.

Lubisch W, Beckenbach E, Bopp S, Hofmann HP, Kartal A, Kästel C, Lindner T, Metz-Garrecht M, Reeb J, Regner F, Vierling M, Möller A (June 2003). "Benzoylalanine-derived ketoamides carrying vinylbenzyl amino residues: discovery of potent water-soluble calpain inhibitors with oral bioavailability". J. Med. Chem. 46 (12): 2404–12. PMID 12773044. doi:10.1021/jm0210717.

Nimmrich V, Reymann KG, Strassburger M, Schöder UH, Gross G, Hahn A, Schoemaker H, Wicke K, Möller A (April 2010). "Inhibition of calpain prevents NMDA-induced cell death and beta-amyloid-induced synaptic dysfunction in hippocampal slice cultures". Br. J. Pharmacol. 159 (7): 1523–31. PMC 2850408. PMID 20233208. doi:10.1111/j.1476-5381.2010.00652.x.

Koumura A, Nonaka Y, Hyakkoku K, Oka T, Shimazawa M, Hozumi I, Inuzuka T, Hara H (November 2008). "A novel calpain inhibitor, ((1S)-1((((1S)-1-benzyl-3-cyclopropylamino-2,3-di-oxopropyl)amino)carbonyl)-3-methylbutyl) carbamic acid 5-methoxy-3-oxapentyl ester, protects neuronal cells from cerebral ischemia-induced damage in mice". Neuroscience 157 (2): 309–18. PMID 18835333. doi:10.1016/j.neuroscience.2008.09.007.

nih.gov

ncbi.nlm.nih.gov

Huang Y, Wang KK (August 2001). "The calpain family and human disease". Trends Mol Med 7 (8): 355–62. PMID 11516996. doi:10.1016/S1471-4914(01)02049-4.

Suzuki K, Hata S, Kawabata Y, Sorimachi H (February 2004). "Structure, activation, and biology of calpain". Diabetes. 53. Suppl 1: S12–8. PMID 14749260. doi:10.2337/diabetes.53.2007.s12.

Liu J, Liu MC, Wang KK (April 2008). "Calpain in the CNS: from synaptic function to neurotoxicity". Sci. Signal. 1 (14): re 1. PMID 18398107. doi:10.1126/stke.114re1.

Castillo MR, Babson JR (October 1998). "Ca²⁺-dependent mechanisms of cell injury in cultured cortical neurons". Neuroscience 86 (4): 1133–44. PMID 9697120. doi:10.1016/S0306-4522(98)00070-0.

worldcat.org

Calpaína (Galician Wikipedia)

archive.org

arizona.edu

ag.arizona.edu

doi.org

dx.doi.org

handle.net

hdl.handle.net

nih.gov

ncbi.nlm.nih.gov

reference.com

dictionary.reference.com

ufl.edu

news.ufl.edu

umich.edu

deepblue.lib.umich.edu

web.archive.org

worldcat.org

zenodo.org